Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Chabannes

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
L'Encephale|December 1, 1995
[Antidepressive agents and neuroses]J P Chabannes
Therapie|November 1, 1990
[Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care]J P Chabannes, P Lemoine
Soins. Psychiatrie|December 1, 1981
[Biologic therapy of schizophrenia]P A Lambert, J P Chabannes
L'Encephale|January 1, 1984
[A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials]P A Lambert, J P Chabannes
L'Encephale|November 1, 1996
[Alzheimer's disease and informed consent of incapacitated people: propositions aimed at improving the procedure]J Gailledreau, P Schlecht, J P Chabannes
Current Medical Research and Opinion|August 31, 2002
Switching antipsychotic medications: general recommendations and switching to amisulprideT Burns, J P Chabannes, K Demyttenaere
Current Medical Research and Opinion|September 24, 2004
The role of captodiamine in the withdrawal from long-term benzodiazepine treatmentC Mercier-Guyon, J P Chabannes, P Saviuc
L'Encephale|December 22, 1999
[The use of therapeutic isolation and confinement in psychiatry. A prospective study]J Palazzolo, J M Chignon, J P Chabannes
Acta Psychiatrica Belgica|March 1, 1981
Some aspects of the French contribution during the past ten years to the study and use of injectable long-acting neurolepticsP A Lambert, G Guinot, J P Chabannes
L'Encephale|January 7, 1998
[Social trajectory and schizophrenia]J P Chabannes, F Crespo, O Martinez, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
L'Encephale|December 1, 1995
[Antidepressive agents and neuroses]J P Chabannes
Therapie|November 1, 1990
[Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care]J P Chabannes, P Lemoine
Soins. Psychiatrie|December 1, 1981
[Biologic therapy of schizophrenia]P A Lambert, J P Chabannes
L'Encephale|January 1, 1984
[A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials]P A Lambert, J P Chabannes
L'Encephale|November 1, 1996
[Alzheimer's disease and informed consent of incapacitated people: propositions aimed at improving the procedure]J Gailledreau, P Schlecht, J P Chabannes
Current Medical Research and Opinion|August 31, 2002
Switching antipsychotic medications: general recommendations and switching to amisulprideT Burns, J P Chabannes, K Demyttenaere
Current Medical Research and Opinion|September 24, 2004
The role of captodiamine in the withdrawal from long-term benzodiazepine treatmentC Mercier-Guyon, J P Chabannes, P Saviuc
L'Encephale|December 22, 1999
[The use of therapeutic isolation and confinement in psychiatry. A prospective study]J Palazzolo, J M Chignon, J P Chabannes
Acta Psychiatrica Belgica|March 1, 1981
Some aspects of the French contribution during the past ten years to the study and use of injectable long-acting neurolepticsP A Lambert, G Guinot, J P Chabannes
L'Encephale|January 7, 1998
[Social trajectory and schizophrenia]J P Chabannes, F Crespo, O Martinez, et al.
Pageof 3